1.14.99.58	(2E)-2-[4-(dimethylamino)benzylidene]hydrazinecarboximidamide	binding affinity 0.030 mM	63814	
1.14.99.58	(2E)-2-[[4-(dimethylamino)phenyl]methylidene]hydrazinecarboximidamide	binding affinity is 0.030 mM, complete inhibition	68345	
1.14.99.58	(2Z)-4-[(4-anilinophenyl)amino]-4-oxobut-2-enoic acid	binding affinity 0.0201 mM, above 0.25 mM significant decrease in growth of strain on heme as sole source of iron	63812	
1.14.99.58	(2Z)-N'-[(1Z)-pyridin-3-ylmethylene]-2-(pyridin-3-ylmethylene)hydrazinecarboximidohydrazide	binding affinity 0.0159 mM	63810	
1.14.99.58	(2Z)-N'-[(1Z)-pyridin-3-ylmethylidene]-2-(pyridin-3-ylmethylidene)hydrazinecarboximidohydrazide	binding affinity is 0.0159 mM, complete inhibition	68278	
1.14.99.58	1-(2,4-dinitrophenyl)methanamine	binding affinity 0.187 mM	63815	
1.14.99.58	2-(4-chlorophenyl)-N'-[(1E)-1H-indol-3-ylmethylidene]acetohydrazide	binding affinity is 0.0158 mM, complete inhibition	68387	
1.14.99.58	2-(4-chlorophenyl)-N'-[(1Z)-1H-inden-3-ylmethylene]acetohydrazide	binding affinity 0.0158 mM, above 0.25 mM significant decrease in growth of strain on heme as sole source of iron	63811	
1.14.99.58	4-oxo-4-[[4-(phenylamino)phenyl]amino]butanoic acid	binding affinity is 0.0201 mM, complete inhibition	68239	
1.14.99.58	4-[(2-hydroxyphenyl)amino]naphthalene-1,2-dione	binding affinity is 0.0728 mM, partial inhibition	68266	
1.14.99.58	N'-(pyridin-4-ylcarbonyl)pyridine-4-carbohydrazide	binding affinity is 0.0447 mM, partial inhibition	68652	
1.14.99.58	N-(4-imidazo[1,2-a]pyridin-2-ylphenyl)-2-nitrobenzamide	binding affinity is 0.0061 mM, complete inhibition	63813	
1.14.99.58	N-(4-imidazo[1,2-a]pyridin-2-ylphenyl)-3-nitrobenzamide	binding affinity 0.0061 mM	66029